Helixgate https://validator.w3.org/feed/docs/rss2.html STAT+: Top health officials highlight efforts to make medical records more portable BBB Access Route via Proteomic Vascular Mapping New rules for CDC vaccine panel aim to address lawsuit, empower Kennedy’s allies FDA plans another safety study of abortion drug after court order AbbVie suggests new interpretation of ‘patient’ is necessary in 340B lawsuit Vivatides gets $54M; Wegovy drops cold chain in EU; Gilead takes Kymera option With oral obesity race underway, all eyes are on Lilly’s Foundayo launch Trump administration admits a glaring error in its accusations about New York health care fraud For AI To Have Impact, the Industry Must Align on Data STAT+: GSK says goodbye to leucovorin (again) GSK again pulls application for leucovorin, touted by FDA as potential autism treatment Novo’s double departures: As GLP-1 luminary retires, an obesity leader goes to Boehringer Ingelheim Invivyd reveals plans to test an antibody drug against measles Women have awaited a revolution in menopause. It hasn’t arrived. Cancer Drug Shortfalls Tied to How BET Inhibitors Hit BRD2 and BRD4 Differently Labguru Customer Portal Launched for CRO/CDMO and Client Collaboration Chasing a tough-to-treat lung disease, Avalyn plans an IPO Opinion: What public health can learn from the MAHA movement FDA lifts MacroGenics hold; Oxford and Bristol Myers team up Organ-on-Chip Integrated Into Preclinical Glioblastoma Research STAT+: A new health care blueprint from a key Democratic think tank Team approach to lowering high blood pressure worked even in ‘a tough landscape’ STAT+: Replimune skin cancer drug that became FDA flashpoint is rejected again Neuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling Everyone has a mental health chatbot. Now what? STAT+: FDA rejects an industry proposal to deregulate some AI devices STAT+: Pharmalittle: We’re reading about top pharma lobbyist stepping down, genes and GLP-1 drugs, and more Innovent’s CDMO gets green light to make biologics at large Chinese plant Roche sticks with C4T, adding up to $1B for molecular glue partnership Research uncovers previously unknown recessive condition  Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors Automation, Collaboration and the Future of Advanced Therapies STAT+: Influential Democratic think tank pushes plan for government to lower health care costs Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests Your DNA has a secret “second code” that decides which genes get silenced STAT+: Biotech VCs, used to a winning formula in drug development, face disruption Opinion: Tastiness is not why people overeat STAT+: Which U.S. metros have the highest health spending? The answer might surprise you Pulmonary fibrosis biotech Avalyn Pharma files for IPO Single-Cell Atlas of Maternal–Fetal Interface Sheds Light on Pregnancy Complications Esophagus engineering tackles function Sidewinder secures $137M to advance ‘precision’ ADCs PhRMA head Steve Ubl to step down, according to sources China-based AI biotech Ailux hires CSO, eyes clinic in 2027 With 3 quick buyouts, Gilead leans into its latest transformation Forecasting Protein Aggregation with an Improved Algorithm Avalyn plots IPO to push inhaled pulmonary fibrosis pipeline through clinic Activist investor revives campaign to overhaul Novavax board Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application Home